For example, hormone receptors (ER and PR), growth factor receptor (HER2, EGFR, and IGF-1R), and angiogenic factors (VEGFR, integrin αvβ3) have been adopted as imaging targets to detect/stage the breast cancer and monitor treatment efficacy. Here, ESR1 is linked to breast carcinoma.